Publication | Closed Access

Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data

UrologyRadiation MedicineRadiation TherapySitu Gene TherapyMedicineProstatic DiseaseOncologyRadiation OncologyPsa ResponsePhase I–ii Trial